Kui Wang

Kui Wang is Associate Principal Scientist, RNA Technology at Verve Therapeutics, where he leads mRNA manufacturing for the company. He has in-depth experience in drug delivery, nanomaterials, and gene therapy. Prior to Verve, he was a scientist at Casebia Therapeutics, where he was responsible for mRNA production and LNP formulation. He has authored and co-authored more than 40 publications. Dr. Wang earned a dual Ph.D. in materials science and engineering and nanotechnology and molecular engineering from the University of Washington. He completed his postdoctoral training at the Massachusetts Institute of Technology and Brigham and Women’s Hospital.